Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review

  • ID: 4282150
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Glenmark Pharmaceuticals Ltd (Glenmark) is a pharmaceutical company which focuses on the discovery of new chemical entities (NCEs) and new biological entities (NBEs). The company's formulations business encompasses therapeutic areas such as dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, central nervous system, and oncology. It also offers a wide range of generic products. The company manufactures and supplies active pharmaceutical ingredients (APIs). Glenmark developed a proprietary platform, Bispecific Engagement by antibodies based on the T-cell receptor (BEAT) for production of bispecific antibodies for the treatment of HER2+ cancers. The company markets its products in North America, South America, Asia-Pacific and Africa. Glenmark is headquartered in Mumbai, Maharashtra, India.

Glenmark Pharmaceuticals Ltd Key Recent Developments

Feb 09, 2018: Glenmark’s consolidated revenue at Rs. 22,036.62 Mn for Q3 FY 2017 - 18
Jan 25, 2018: Indian pharma cos get record 300 USFDA generic drug nods in 2017
Nov 28, 2017: Glenmark Pharmaceuticals: USFDA Audit -Baddi Unit
Nov 02, 2017: Glenmark Appoints Mr. V. S. Mani as Predent & Global Chief Financial Officer
Sep 11, 2017: Glenmark Pharmaceuticals receives ANDA approval for Propafenone Hydrochloride Extended - Release Capsules USP, 225 mg, 325 mg, and 425 mg

This comprehensive SWOT profile of Glenmark Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Glenmark Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Glenmark Pharmaceuticals Ltd - Key Information
  • Glenmark Pharmaceuticals Ltd - Overview
  • Glenmark Pharmaceuticals Ltd - Key Employees
  • Glenmark Pharmaceuticals Ltd - Key Employee Biographies
  • Glenmark Pharmaceuticals Ltd - Key Operational Heads
  • Glenmark Pharmaceuticals Ltd - Major Products and Services
  • Glenmark Pharmaceuticals Ltd - History
  • Glenmark Pharmaceuticals Ltd - Company Statement
  • Glenmark Pharmaceuticals Ltd - Locations And Subsidiaries
  • Glenmark Pharmaceuticals Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Glenmark Pharmaceuticals Ltd - Business Description
  • Glenmark Pharmaceuticals Ltd - Corporate Strategy
  • Glenmark Pharmaceuticals Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Glenmark Pharmaceuticals Ltd - Strengths
  • Glenmark Pharmaceuticals Ltd - Weaknesses
  • Glenmark Pharmaceuticals Ltd - Opportunities
  • Glenmark Pharmaceuticals Ltd - Threats
  • Glenmark Pharmaceuticals Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • Glenmark Pharmaceuticals Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Glenmark Pharmaceuticals Ltd, Key Information
  • Glenmark Pharmaceuticals Ltd, Key Ratios
  • Glenmark Pharmaceuticals Ltd, Share Data
  • Glenmark Pharmaceuticals Ltd, Major Products and Services
  • Glenmark Pharmaceuticals Ltd, History
  • Glenmark Pharmaceuticals Ltd, Key Employees
  • Glenmark Pharmaceuticals Ltd, Key Employee Biographies
  • Glenmark Pharmaceuticals Ltd, Key Operational Heads
  • Glenmark Pharmaceuticals Ltd, Other Locations
  • Glenmark Pharmaceuticals Ltd, Subsidiaries
  • Glenmark Pharmaceuticals Ltd, Key Manufacturing facilities
  • Glenmark Pharmaceuticals Ltd, Key Competitors
  • Glenmark Pharmaceuticals Ltd, SWOT Analysis
  • Glenmark Pharmaceuticals Ltd, Ratios based on current share price
  • Glenmark Pharmaceuticals Ltd, Annual Ratios
  • Glenmark Pharmaceuticals Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Glenmark Pharmaceuticals Ltd, Performance Chart
  • Glenmark Pharmaceuticals Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown